Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Gujarat Themis Biosyn Ltd
Acquired Company
MicroBiopharm Japan Ltd
Mumbai
JapanManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyDescription
Gujarat Themis Biosyn Ltd. has secured $58 million in private credit funding to support its acquisition of MicroBiopharm Japan Co. The deal, valued at ¥21.5 billion, reflects the trend of Asian companies utilizing private credit for overseas expansion. The financing is expected to enhance Gujarat Themis' growth and investments in the Japanese market.
Fundz sees it the moment Gujarat Themis Biosyn Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired MicroBiopharm Japan Ltd?
MicroBiopharm Japan Ltd was acquired by Gujarat Themis Biosyn Ltd, based in Mumbai. The deal was reported on September 29, 2026. Gujarat Themis Biosyn Ltd is a pharmaceutical company focused on developing and marketing a range of therapeutic products. The company specializes in anti-tuberculosis and anti-infective therapies. Gujarat Themis Biosyn Ltd is privately held and operates in Manufacturing.
When did Gujarat Themis Biosyn Ltd acquire MicroBiopharm Japan Ltd?
Gujarat Themis Biosyn Ltd's acquisition of MicroBiopharm Japan Ltd was reported on September 29, 2026. Gujarat Themis Biosyn Ltd. has secured $58 million in private credit funding to support its acquisition of MicroBiopharm Japan Co. The deal, valued at ¥21.5 billion, reflects the trend of Asian companies utilizing private credit for overseas expansion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MicroBiopharm Japan Ltd do?
MicroBiopharm Japan Co., Ltd. (MBJ) is a well-established Japanese company with over sixty years of experience in fermentation and microbial-based R&D. It is privately held, operating in Manufacturing, and is based in Japan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.